The Center For Modeling Optimal Outcomes®
                      "The Think Tank For Creativity & Innovation®" 

Genesis of Personalized Medicine & Research Concepts

 

The information contained herein is intended to provide a basic foundation for the scientifically verifiable processes that will lead to the evolution of personalized medicine.

 

How did we evolve to offer unparalleled IP for personalized medicine?

While working on the dynamics of logic and emotion in decision making and the cognitive processes associated with change inertia, the efforts of the members of The Center led them into the study of neurohormones.

 

This process identified unique corollary relationships between neurohormones. Intrigued by the apparent patterns, the team identified  added a research biologist and formed a separate Life Sciences group to investigate published scientific literature and studies to determine if the pattern would also apply to genes (proteins). The group's research confirmed that the pattern remained consistent. The group then called upon chemistry and physics advisors to apply the pattern in physical sciences.

 

It became apparent that the pattern of corollary relationships (the "model") could be applied to scientific processes for maintaining equilibrium (balance or homeostasis) throughout the body's substances.

 

While the global research community knows that homeostasis exists, there remains no mechanism for evaluating homeostatic relationships between the body's substances that can be validated by medical researchers. For clarification, by definition, homeostasis is the state of balance that, practically speaking, provides "wellness." To have balance, a mutualistic relationship must exist between "substances."

 

The Center's formulation of the Epigenetic Model for Homestasis (EMH), converts the tacit knowledge of the dynamics of homeostasis in the body into an explicit, replicable model.

 

Applying The Center's model to personalized medicine and research

Epigenetics has evolved as the future for medical research because DNA does not address all of the compositional substances in the body (e.g. minerals, carbohydrates and minerals). Accordingly, while DNA will be an integral part of future research, the full potential for the identification of causal paths of illnesses and diseases will involve epigenetics.

 

The evolution of personalized medicine will be driven by what is known today as epigenetics, theranostics and a third component  used to assess the correlational aspects between compositional substances of the body; the Epigenetic Model for Homeostasis (EMH).

 

A recent article in Time Magazine explained the emphasis on epigenetics as the new frontier of research into the causal paths of illnesses and diseases.  http://www.time.com/time/health/article/0,8599,1951968,00.html

 

Specific questions or inquiries regarding the work of The Center's Life Sciences group relative to research applications should be directed to Matthew Gyulay at mgyulay@TheCenterNJ.com